ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 517

Overexpression of BMP6 Is Associated with Loss of Salivary Gland Activity in Sjögren’s Syndrome Patients and Mice

Hongen Yin1, Javier Cabrera-Perez1, Zhennan Lai1, Drew Michael2, Melodie Weller1, Bill Swaim1, Noreen Rana1, Xibao Liu1, Ilias Alevizos3, Indu Ambudkar4 and John A. Chiorini1, 1Mptb, NIH/NIDCR, Bethesda, MD, 2Mptb, NIDCR, Bethesda, MD, 3Sjogren's Clinic, NIDCR/ NIH #10 1N110, Bethesda, MD, 4Molecular Physiology and Therapeutics Branch, NIDCR, Bethesda, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Title: Sjögren's Syndrome - Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

A hallmark of Sjögren’s syndrome (SS) is the loss of activity in secretory epithelia, specifically the larcrimal and salivary glands. The mechanism(s) driving this disorder are poorly understood and may involve a combination of environmental and genetic factors. To date extensive efforts have been focused on understanding the changes in the immune system in these patients, however little is understood regarding the changes in the epithelia associated with the loss of gland activity.

Methods:

To identify genes associated with changes in the epithelia, RNA was isolated from patients with both low flow and low lymphocytic infiltrates (focus score) and used to probe customized high density microarrays.  After normalization, the signal from the patient RNA samples was then compared to the signal from RNA isolated from healthy volunteers.  The list of differentially expressed genes was then filtered for genes associated with salivary gland specific cell types.

Results:

A significant increase in expression of the bone morphogenic protein 6 (BMP6) was observed in RNA isolated from patients compared with healthy volunteers. Overexpression of BMP6 locally in the salivary gland or lacrimal glands of mice resulted in the loss of fluid secretion as well as changes in the connective tissue of the salivary gland. Assessment of the fluid movement in either isolated acinar cells of mice overexpressing BMP6 or HSG cells cultured in the presence of BMP6 identified a loss in volume regulation in these cells.  Loss of fluid movement also correlated with a decrease in sodium concentration in the saliva. Lymphocytic infiltration in SMG of BMP6 overexpressing mice was increased. No significant changes were found in proinflammatory cytokines production, neither the auto-antibodies associated with SS, such as anti-Ro/SSA, anti-La SSB and anti-nuclear antibody (ANA) after BMP6 overexpression.

Conclusion:

Our study identified BMP6 as a novel gene associated with xerostomia associated with Sjögren’s syndrome, which may become a new target for therapeutic intervention. In mice, a loss of salivary and lacrimal gland function can be induced by overexpression of BMP6, which further support our finding in patients. This study suggests the loss of salivary gland function can be separated from the autoantibodies and proinflammatory cytokines associated with this disease.


Disclosure:

H. Yin,
None;

J. Cabrera-Perez,
None;

Z. Lai,
None;

D. Michael,
None;

M. Weller,
None;

B. Swaim,
None;

N. Rana,
None;

X. Liu,
None;

I. Alevizos,
None;

I. Ambudkar,
None;

J. A. Chiorini,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/overexpression-of-bmp6-is-associated-with-loss-of-salivary-gland-activity-in-sjogrens-syndrome-patients-and-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology